| Name | (2R,3R,4R,5R)-5-(6-amino-1-methyl-2H-purin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol |
|---|---|
| Synonyms |
2'-O-Methyl-1-methyladenosine
N1,O2'-Dimethyladenosine RNA modified nucleoside m1Am 2'-O-methyl-1-methyladenosine 1,2'-O-dimethyladenosine 2'-O-Methyl-N1-methyladenosine Adenosine, 1-methyl-2'-O-methyl 2’-O-Methyl-N1-methyl adenosine (2R,3R,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-ol Adenosine,1-methyl-2'-O-methyl- (9CI) |
| Description | 2’-O-Methyl-N1-methyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C12H17N5O4 |
|---|---|
| Molecular Weight | 295.29 |
| Exact Mass | 297.14400 |
| PSA | 118.36000 |